Oaktree Capital Management »

Intercept Pharmaceuticals In Note 2.000 5/1 bnd shares owned by Oaktree Capital Management

Quarter-by-quarter ownership of Intercept Pharmaceuticals In Note 2.000 5/1 bnd shares owned by Oaktree Capital Management from 13F filings

Historical chart of Oaktree Capital Management investment in Intercept Pharmaceuticals In Note 2.000 5/1 bnd

Tip: Access up to 7 years of quarterly data

All positions including Intercept Pharmaceuticals In Note 2.000 5/1 bnd held by Oaktree Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intercept Pharmaceuticals In Note 2.000 5/1 bnd by Oaktree Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $7.2M 7.3M 0.99
2023-06-30 $9.5M 12M 0.80
2023-03-31 $7.3M 8.8M 0.83
2022-12-31 $6.3M 8.4M 0.75
2022-09-30 $4.5M 5.9M 0.76